Research Papers:

Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer

Lutao Du _, Xiumei Jiang, Weili Duan, Rui Wang, lishui Wang, Guixi Zheng, Keqiang Yan, Lili Wang, Juan Li, Xin Zhang, Hongwei Pan, Yongmei Yang and Chuanxin Wang

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:40832-40842. https://doi.org/10.18632/oncotarget.16586

Metrics: PDF 2017 views  |   HTML 2516 views  |   ?  


Lutao Du1, Xiumei Jiang1, Weili Duan1, Rui Wang1, lishui Wang1, Guixi Zheng1, Keqiang Yan2, Lili Wang1, Juan Li1, Xin Zhang1, Hongwei Pan1, Yongmei Yang1 and Chuanxin Wang3

1Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, 250012, Shandong Province, China

2Department of Urology, Qilu Hospital of Shandong University, Jinan, 250012, Shandong Province, China

3Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan 250033, Shandong, China

Correspondence to:

Chuanxin Wang, email: [email protected]

Keywords: microRNA, bladder cancer, diagnosis, recurrence, urine

Received: October 22, 2016    Accepted: March 14, 2017    Published: March 28, 2017


Urinary microRNAs (miRNAs) are potential biomarkers for the noninvasive diagnosis of bladder cancer (BC). In this study, we aimed to develop a urinary miRNAs panel for diagnosing and predicting recurrence of BC. Genome-wide miRNAs analysis by deep sequencing followed by two phases of quantitative real-time PCR assays were performed on urine supernatant of 276 BC patients and 276 controls. We identified a seven-miRNA panel (miR-7-5p, miR-22-3p, miR-29a-3p, miR-126-5p, miR-200a-3p, miR-375, and miR-423-5p) that provided high diagnostic accuracy of BC with an AUC of 0.923 and 0.916 in training and validation set, respectively. The corresponding AUCs of this panel for Ta, T1 and T2-T4 were 0.864, 0.930 and 0.978, significantly higher than those of urine cytology, which were 0.531, 0.628 and 0.724, respectively (all p < 0.05). Moreover, Kaplan–Meier analysis showed that nonmuscle-invasive BC (NMIBC) patients with high miR-22-3p and low miR-200a-3p level had worse recurrence-free survival (RFS) (p = 0.002 and 0.040, respectively). Multivariate Cox regression analysis revealed that miR-22-3p and miR-200a-3p were independently associated with RFS of NMIBC (p = 0.024 and 0.008, respectively). In conclusion, our results suggested that urinary miRNAs may have considerable clinical value in diagnosis and recurrence prediction of BC.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 16586